HCW Biologics Inc (HCWB)

Name: HCW Biologics Inc (HCWB) Share Price Today, Stock Analysis, Annual Report | Value Research
Brand: HCW Biologics Inc (HCWB)

Stock Card

$2.87

$-0.49 (-14.46%)

As on 03-Sep-2026 16:24EDT

Market cap

$6 Mln

Revenue (TTM)

$7 Mln

P/E Ratio

P/B Ratio

0.8

Div. Yield

0 %

HCW Biologics Inc (HCWB) Share Price

Compare

High: Low: Return:

Price P/E Ratio P/B Ratio

Stock Range

Today’s Range

Low: 2.70 High: 3.34

52 Week Range

Low: 1.50 High: 36.65

Liquidity

Low Moderate High

Fundamentals

Net Profit (TTM)

$0 Mln
ROE

-1.5 %
ROCE

-- %
Industry P/E

--
EV/EBITDA

-3.6
Debt to Equity

0
Book Value

$--
EPS

$-13.1
Face value

--
Shares outstanding

1,836,324

5 Years Aggregate

CFO

$-61.07 Mln

EBITDA

$-64.35 Mln

Net Profit

$-65.07 Mln

Company	YTD	1 Month	3 Months	1 Year	3 Years	5 Years	10 Years
HCW Biologics Inc (HCWB)	-50.7	-10.3	-73.3	-91.1	-81.0	-68.6	--
BSE Sensex^*	-9.6	-2.7	2.9	-5.0	5.4	5.7	10.4
S&P Small-Cap 600^#	-5.8	-5.3	-13.7	-6.3	5.3	3.0	5.5

As on 03-Sep-2026 | *As on 04-Sep-2026 | #As on 26-Oct-2023

Company	2025	2024	2023	2022
HCW Biologics Inc (HCWB)	-94.6	-63.3	-36.0	-17.5
S&P Small-Cap 600	4.0	7.0	13.9	-17.4
BSE Sensex	9.1	8.1	18.7	4.4

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details

Key Ratios

View Details

Peers

View Details

Company	Price ($)	Market Cap ($ Mln)	Revenue (TTM)	Net Profit (TTM)	OPM (%)	ROE (%)	P/E	P/B
HCW Biologics Inc (HCWB)	2.9	6.3	6.7	-4.9	-72.5	-96.6	--	0.8
Arrowhead Pharmaceuticals (ARWR)	86.5	11,993.9	669.5	-320.0	-0.8	-71.1	--	26.9
Cytokinetics Inc (CYTK)	74.0	10,022.2	71.0	-894.0	-1,175.8	--	--	60.3
Exelixis (EXEL)	59.1	13,491.7	2,435.9	860.6	31.0	43	17.4	7.4
Halozyme Therapeutics (HALO)	110.8	11,957.0	1,663.7	413.6	36.3	430	30.9	84.5
Krystal Biotech (KRYS)	371.5	10,402.8	440.5	241.5	33.4	18.7	44.1	7.8
Madrigal Pharmaceuticals (MDGL)	542.6	12,332.1	1,283.9	-325.1	-19.0	-57.7	--	24.0
Medpace Holdings (MEDP)	593.4	16,765.1	2,782.3	491.5	21.1	110.1	35.2	39.3
Praxis Precision MedicinesÂ Inc (PRAX)	355.2	9,625.4	0.0	-339.1	--	-30.6	--	7.6
Protagonist Therapeutics (PTGX)	148.8	9,339.4	282.0	82.9	-28.6	11.4	140.1	11.5

Shareholding Pattern

View Details

About HCW Biologics Inc (HCWB)

HCW Biologics Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and diseases in the United States. Its lead products include HCW11-018b, a novel,... tetra-valent T-Cell engager; HCW11-040, a multifunctional fusion molecule that is a combination of cytokines and pembrolizumab; and HCW9302, injectable and interleukin 2 (IL-2) fusion protein complex, which is in clinical trial in patients with alopecia areata diseases. The company also develops HCW9201, a fusion protein designed as a reagent to use in the production of natural killer (NK) cell-based therapies; HCW9206, a fusion protein designed as a reagent to use in the production of CAR-therapies for the treatment of infectious diseases; and HCW11-006, a multi-functional immune cell stimulator. It has a license agreement with Wugen Inc. to develop cell therapy-based treatments; and a license, research and co-development agreement with WY Biotech Co., Ltd. for its preclinical molecule. HCW Biologics Inc. was incorporated in 2018 and is headquartered in Miramar, Florida. Read more

Founder, CEO, Director & Secretary

Dr. Hing C. Wong Ph.D.
Founder, CEO, Director & Secretary

Dr. Hing C. Wong Ph.D.
Headquarters

Miramar, FL
Website

https://www.hcwbiologics.com

FAQs for HCW Biologics Inc (HCWB)

What is the current share price of HCW Biologics Inc (HCWB) Today?

The share price of HCW Biologics Inc (HCWB) is $2.87 (NASDAQ) as of 03-Sep-2026 16:24 EDT. HCW Biologics Inc (HCWB) has given a return of -81.02% in the last 3 years.

What is the current PB & PE ratio of HCW Biologics Inc (HCWB)?

Since, TTM earnings of HCW Biologics Inc (HCWB) is negative, P/E ratio is not available.
The P/B ratio of HCW Biologics Inc (HCWB) is 0.78 times as on 28-Aug-2026, a 85 discount to its peers’ median range of 5.18 times.

PE & PB ratio at the end of financial year.

Year	P/E Ratio	P/B Ratio
2025	-0.04	0.12
2024	-0.10	-0.43
2023	-1.77	3.28
2022	-0.77	0.31
2021	-0.89	0.22

What is the 52 Week High and Low of HCW Biologics Inc (HCWB)?

The 52-week high and low of HCW Biologics Inc (HCWB) are Rs 36.65 and Rs 1.50 as of 04-Sep-2026.

What is the market cap of HCW Biologics Inc (HCWB)?

HCW Biologics Inc (HCWB) has a market capitalisation of $ 6 Mln as on 28-Aug-2026. As per SEBI classification, it is a Small Cap company.

Should I invest in HCW Biologics Inc (HCWB)?

Before investing in HCW Biologics Inc (HCWB), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.

Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.